文献速递先天性心脏病外科

儿科心脏网络残余病变评分研究:设计与目标

The Pediatric Heart Network Residual Lesion Score Study: Design and objectives.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-11-15

残余病变评分(RLS)是一种基于临床和超声特征评估先心病术后残余病变的新工具,分为1-3级。该多中心前瞻性研究旨在分析常见先心病手术中残余病变对结局的影响,假设RLS可预测术后1年内的不良事件、资源利用、死亡和再干预。

要点

  • RLS根据术后残余病变程度分为1级(无/轻微)、2级(次要)、3级(主要或出院前再干预)。
  • 研究纳入≤12月龄接受五种先心病根治手术的婴儿,排除可能独立影响主要终点的重大心外异常。
  • 主要终点为术后30天(Norwood手术为60天)内存活且出院的天数,所有分析按手术类型分别进行。

核心结论

  • 这是首个针对先心病手术结局评估和质量改进工具的多中心前瞻性验证研究。

研究设计与样本

  • 多中心前瞻性队列研究,纳入≤12月龄接受完全性房室间隔缺损、法洛四联症、d-TGA伴或不伴室间隔完整、单心室(Norwood手术)、主动脉缩窄或中断/发育不良弓伴室间隔缺损根治手术的婴儿。
  • 排除可能独立影响主要终点的重大先天性或获得性心外异常患儿。

主要发现

  • RLS将术后发现分为1级(无/轻微残余)、2级(次要残余)、3级(主要残余或出院前因残余再干预)。
  • 假设RLS可预测术后不良事件、资源利用、死亡和再干预至术后1年。

关键数值与推荐

  • 主要终点为术后30天(Norwood手术为60天)内存活且出院的天数。
  • 次要结局包括≥1次早期重大术后不良事件、ICU和住院天数、初始和总通气时间、出院后死亡/移植、出院后非计划再干预及费用。

临床怎么用

  • RLS可用于先心病术后残余病变的标准化评估,辅助预测结局和指导质量改进。

局限性

  • 研究仅纳入特定先心病手术类型和≤12月龄婴儿,排除重大心外异常,结果外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The Residual Lesion Score (RLS) was developed as a novel tool for assessing residual lesions after congenital heart operations based on widely available clinical and echocardiographic characteristics. The RLS ranks postoperative findings as follows: Class 1 (no/trivial residua), Class 2 (minor residua), or Class 3 (major residua or reintervention before discharge for residua). The multicenter prospective RLS study aims to analyze the influence of residual lesions on outcomes in common congenital cardiac operations. We hypothesize that RLS will predict postoperative adverse events, resource utilization, mortality, and reinterventions by 1 year postoperatively. METHODS: The study cohort consisted of infants aged ≤12 months undergoing definitive surgery for complete atrioventricular septal defect, tetralogy of Fallot, dextro-transposition of the great arteries with or without intact ventricular septum, single ventricle (Norwood procedure), and coarctation or interrupted/hypoplastic arch with ventricular septal defect. Children with major congenital or acquired extracardiac anomalies that could independently affect the primary end point, which was number of days alive and out of the hospital within 30 days of surgery (60 days for Norwood procedure), were excluded. Secondary outcomes included ≥1 early major postoperative adverse event; days of intensive care unit and hospital stay, and initial and total ventilator time; mortality/transplant after discharge; unplanned reinterventions after discharge; and cost. All analyses will be performed separately by surgical operation. CONCLUSIONS: This is the first multicenter prospective validation of a tool for surgical outcome assessment and quality improvement specific to congenital heart surgery.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Nathan M, Trachtenberg FL, Van Rompay MI, et al. The Pediatric Heart Network Residual Lesion Score Study: Design and objectives. J Thorac Cardiovasc Surg. 2019. PMID: 31870553. doi:10.1016/j.jtcvs.2019.10.146

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。